Advanced search
Publication Cover
Minimally Invasive Therapy & Allied Technologies Volume 31, 2022 - Issue 6
Submit an article Journal homepage
91
Views
1
CrossRef citations to date
0
Altmetric
Articles

Alternative access in high-risk patients in the era of transfemoral aortic valve replacement

Alina Zubarevicha Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2444-5747
ORCID Icon,
Marcin Szczechowicza Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
,
Rolf-Alexander Jánosib Department of Cardiology, West-German Heart Center Essen, University Hospital Essen, Essen, Germany
,
Alexander Lindb Department of Cardiology, West-German Heart Center Essen, University Hospital Essen, Essen, Germany
,
Tienush Rassafb Department of Cardiology, West-German Heart Center Essen, University Hospital Essen, Essen, Germany
,
Rizwan Malika Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
,
Matthias Thielmanna Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
,
Bastian Schmacka Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
,
Markus Kamlera Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
,
Arjang Ruhparwara Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
,
Alexander Weymanna Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
&
Daniel Wendta Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center Essen, University Hospital Essen, Essen, Germany
 show all
Pages 909-916 | Received 03 Aug 2021, Accepted 30 Nov 2021, Published online: 16 Dec 2021

References

  • Chakos A, Wilson-Smith A, Arora S, et al. Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg. 2017;6(5):432–443.
  • Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–1705.
  • Thielmann M, Wendt D, Eggebrecht H, et al. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement. Ann Thorac Surg. 2009;88(5):1468–1474.
  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607.
  • Webb J, Gerosa G, Lefèvre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64(21):2235–2243.
  • Wendt D, Al-Rashid F, Kahlert P, et al. Conventional aortic valve replacement or transcatheter aortic valve implantation in patients with previous cardiac surgery. J Cardiol. 2015;66(4):292–297.
  • Zhao A, Minhui H, Li X, et al. A Meta-analysis of transfemoral versus transapical transcatheter aortic valve implantation on 30-day and 1-year outcomes. Heart Surg Forum. 2015;18(4):E161–E166.
  • Li X, Kong M, Jiang D, et al. Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg. 2013;8:168.
  • Romano M, Daprati A, Saitto G, et al. Safety and effectiveness of a transaortic approach for TAVI: procedural and midterm outcomes of 265 consecutive patients in a single Centre. Interact Cardiovasc Thorac Surg. 2020;30(3):400–407.
  • Casado AP, Barili F, D'Auria F, et al. Midterm outcomes of transaortic and transapical TAVI in patients with unsuitable vascular anatomy for femoral access: a propensity score inverse probability weight study. J Card Surg. 2021;36(3):872–878.
  • Wendt D, Al-Rashid F, Kahlert P, et al. Low incidence of paravalvular leakage with the Balloon-Expandable Sapien 3 transcatheter heart valve. Ann Thorac Surg. 2015;100:816–819.
  • Kahlert P, Al-Rashid F, Plicht B, et al. Incidence, predictors, origin and prevention of early and late neurological events after transcatheter aortic valve implantation (TAVI): a comprehensive review of current data. J Thromb Thrombolysis. 2013;35(4):436–449.
  • Ramirez Del Val F, Hirji SA, Carreras ET, et al. Clinical significance of greater implantation height with SAPIEN 3 transcatheter heart valve. J Heart Valve Dis. 2018;27:9–16.
  • Schwerg M, Fulde F, Dreger H, et al. Optimized implantation height of the edwards SAPIEN 3 valve to minimize pacemaker implantation after TAVI. J Interv Cardiol. 2016;29(4):370–374.
  • Ochiai T, Chakravarty T, Yoon S-H, et al. Coronary access after TAVR. JACC Cardiovasc Interv. 2020;13(6):693–705.
  • De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv. 2016;9(8):805–813.
  • Wendt D, Shehada S-E, König L, et al. Modified implantation height of the Sapien3™ transcatheter heart valve. Minim Invasive Ther Allied Technol. 2020;29(2):70–77.
  • Sinning J-M, Ghanem A, Steinhäuser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(11):1141–1149.
  • Lanz J, Kim W-K, Walther T, SCOPE I investigators, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019;394(10209):1619–1628.
  • Arsalan M, Squiers JJ, Farkas R, et al. Prognostic usefulness of acute kidney injury after transcatheter aortic valve replacement. Am J Cardiol. 2016;117(8):1327–1331.
  • Yamamoto M, Hayashida K, Mouillet G, et al. Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2013;6(5):479–486.
  • Miura D, Yamada Y, Kusaba S, et al. Influence of preoperative serum creatinine level and intraoperative volume of contrast medium on the risk of acute kidney injury after transfemoral transcatheter aortic valve implantation: a retrospective observational study. BMC Res Notes. 2019;12(1):484.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.